Atropine for the Treatment of Childhood Myopia: Changes after Stopping Atropine 0.01%, 0.1% and 0.5%
Top Cited Papers
- 1 February 2014
- journal article
- research article
- Published by Elsevier BV in American Journal of Ophthalmology
- Vol. 157 (2), 451-457.e1
- https://doi.org/10.1016/j.ajo.2013.09.020
Abstract
No abstract availableThis publication has 17 references indexed in Scilit:
- The M4 muscarinic antagonist MT‐3 inhibits myopia in chick: evidence for site of actionOphthalmic and Physiological Optics, 2011
- Transglutaminases (TGs) in Ocular and Periocular Tissues: Effect of Muscarinic Agents on TGs in Scleral FibroblastsPLOS ONE, 2011
- A combined therapy using stimulating auricular acupoints enhances lower-level atropine eyedrops when used for myopia control in school-aged children evaluated by a pilot randomized controlled clinical trialComplementary Therapies in Medicine, 2008
- Topical Atropine in Retarding Myopic Progression and Axial Length Growth in Children with Moderate to Severe Myopia: A Pilot StudyJapanese Journal of Ophthalmology, 2007
- Atropine for the Treatment of Childhood MyopiaOphthalmology, 2006
- Prevention of Myopia Progression with 0.05% Atropine SolutionJournal of Ocular Pharmacology and Therapeutics, 2006
- The Presence of m1 to m5 Receptors in Human Sclera: Evidence of the Sclera as a Potential Site of Action for Muscarinic Receptor AntagonistsCurrent Eye Research, 2006
- Effects of Different Concentrations of Atropine on Controlling Myopia in Myopic ChildrenJournal of Ocular Pharmacology and Therapeutics, 1999
- The Effectiveness of 0.5% Atropine in Controlling High Myopia in ChildrenJournal of Ocular Pharmacology and Therapeutics, 1997
- Clinical assessment of the arrest of myopia.British Journal of Ophthalmology, 1975